Medicine Prices

One third of the world’s population lacks reliable access to the medicines they need – primarily because they cannot afford to buy them. In the poorest countries of Africa and Asia this figure rises to 50%. HAI and WHO (World Health Organization – create hot link to WHO site) have developed a method to survey the prices people pay for a selection of needed medicines, assess the affordability of some standard treatments and assess price components (mark ups, taxes etc).
Click here to access price information and how to undertake a survey
Essential Innovation : Research and Development to meet public needs

The pharmaceutical sector is failing the public. It is widely recognized that in pharmaceuticals, private sector research and development (R&D) is market driven. The Essential Innovation project seeks to examine the evidence of the success of the current global framework of financing R&D as a mechanism for delivery of drugs, diagnostic tools and other instruments to meet public needs.
Read more about Essential Innovation
Drug Promotion
Public Private Interactions : Enhancing equitable access
to HIV/AIDS medicines : Benefits and risks of public

Growing recognition of the depths and costs of the AIDS crisis have produced at the transnational level, a shift away from a largely public production of health care policy to an institutional framework involving a mix of actors. Private Public Interactions (PPIs) are proposed as a win-win solution to the AIDS pandemic. In practice this method is proving to be difficult. HAI will assess the impact of PPIs on access to medicines at the community and country levels, and contribute to global data collection and policy formulation.
Read more